MGAT1 deficient cells and uses thereof

NZ835436APending Publication Date: 2026-08-28ROCK BIOMEDICAL INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
NZ835436
Authority / Receiving Office
NZ · NZ
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-17
Filing Date
2024-05-16
Publication Date
2026-08-28

Smart Images

  • Figure 1_ABST
    Figure 1_ABST
Patent Text Reader

Abstract

A method for producing a modified cell deficient in mannosy 1 (alpha-l,3-)-glycoprotein beta-l,2-N-acetylglucosaminyltransferase 1 ("MGAT1") activity. Also provided is a CHO cell line deficient in MGAT1 activity produced by the method. Further disclosed are methods for producing a glycoprotein.
Need to check novelty before this filing date? Find Prior Art